REFRACTORY GLIOBLASTOMA
Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-resort drug offered to brain cancer patients
Disease control AVAILABLEThis program provides gallium maltolate (GaM) to adults aged 18 and older with glioblastoma that has returned or is not responding to standard treatments. The goal is to offer a possible treatment option when no others are available. Patients must be able to swallow capsules and …
Matched conditions: REFRACTORY GLIOBLASTOMA
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells take on glioblastoma in first human trial
Disease control Recruiting nowThis early-phase trial is testing a new type of immunotherapy called CAR-T cells in 14 people with glioblastoma that has come back or not responded to treatment. The CAR-T cells are designed to target two proteins found on glioblastoma cells and are given directly into the fluid …
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC